CME Group Inc. $CME Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. lifted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 7.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 87,179 shares of the financial services provider’s stock after purchasing an additional 5,733 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in CME Group were worth $23,555,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the business. Caldwell Trust Co raised its stake in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in CME Group in the 3rd quarter valued at $27,000. Financial Consulate Inc. purchased a new position in CME Group in the third quarter valued at about $28,000. Sagard Holdings Management Inc. acquired a new position in shares of CME Group during the second quarter worth about $30,000. Finally, Corundum Trust Company INC purchased a new stake in shares of CME Group in the third quarter worth about $30,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the topic of several analyst reports. JPMorgan Chase & Co. raised their target price on CME Group from $256.00 to $262.00 and gave the company an “underweight” rating in a report on Thursday, January 22nd. Bank of America lifted their price objective on shares of CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Jefferies Financial Group decreased their target price on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research note on Monday, January 12th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a report on Wednesday, December 17th. Finally, UBS Group reiterated a “neutral” rating on shares of CME Group in a report on Tuesday, January 6th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $292.18.

Read Our Latest Stock Report on CME Group

Insider Buying and Selling

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the sale, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director William R. Shepard bought 251 shares of CME Group stock in a transaction on Tuesday, December 30th. The shares were purchased at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the acquisition, the director owned 258,710 shares in the company, valued at $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.30% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

  • Positive Sentiment: Analysts and data services expect a likely earnings beat ahead of CME’s upcoming release (market consensus/non‑GAAP EPS previews and previews noting the company’s revenue mix). Positive guidance/expectations ahead of the report are supporting the stock. Will CME Group (CME) beat quarterly earnings? CME Group (CME) Earnings Expected to Grow
  • Positive Sentiment: CME expanded crypto derivatives with options on its Bitcoin Friday futures, broadening products for institutional and retail-facing flows — potential to increase volumes and fee revenue as crypto activity grows. CME Group Expands Crypto Offerings With Options On Bitcoin Friday Futures
  • Positive Sentiment: CME issued a self‑certification that could let FanDuel and DraftKings offer Super Bowl parlays on prediction markets using CME infrastructure — a new use case that could drive volume and broaden commercial relationships. FanDuel and DraftKings prediction markets could offer Super Bowl parlays, as CME issues self-certification
  • Positive Sentiment: Reported short interest fell earlier in January (down ~15.6% to ~4.21M shares as of Jan 15), reducing potential downside pressure from short-covering and signaling less bearish positioning. (Data feed)
  • Neutral Sentiment: CME signed a multiyear jersey-patch sponsorship with the Chicago White Sox — increases brand visibility in its hometown market but likely a modest near-term financial impact relative to core derivatives revenue. CME Group Named as First-Ever Chicago White Sox Jersey Patch Sponsor
  • Neutral Sentiment: There is an anomalous/erroneous short‑interest entry showing zero shares for late‑January that appears to be a reporting error — investors should rely on the earlier, validated short‑interest update. (Data feed)

CME Group Trading Up 1.3%

CME opened at $289.83 on Friday. CME Group Inc. has a 12-month low of $233.12 and a 12-month high of $291.76. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $104.51 billion, a PE ratio of 28.08, a P/E/G ratio of 3.22 and a beta of 0.27. The firm’s fifty day moving average price is $274.93 and its 200 day moving average price is $272.27.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.